Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine

被引:36
作者
Brühl, P [1 ]
Kerschbaum, A [1 ]
Kistner, O [1 ]
Barrett, N [1 ]
Dorner, F [1 ]
Gerencer, M [1 ]
机构
[1] Baxter Hyland Immuno, Dept Cellular Immunol, A-1221 Vienna, Austria
关键词
vaccine; influenza virus; Vero cells;
D O I
10.1016/S0264-410X(00)00316-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A candidate trivalent influenza whole virus vaccine produced in a continuous mammalian cell line (Vero), and analogous commercially available egg-derived vaccines, were compared for their ability to induce humoral and cell-mediated immunity in Balb/c mice. Substantial haemagglutination-inhibition titre and high levels of influenza virus-specific IgG were found in all groups of immunized mice, irrespective of the vaccine formulation. The IgG responses were predominantly of IgG1 and IgG2a/2b isotypes. Virus-specific secretory IgA antibodies were detected only in mice immunized intranasally with a live virus, derived either from Vero cells or eggs. T-cell proliferative responses and T-helper 1 type cytokine release was significantly higher in mice immunized with Vero cell-derived influenza vaccine compared to egg-derived vaccine formulations. We have demonstrated that the immunogenicity df the trivalent Vero cell-derived whole influenza virus vaccine was comparable to that of the equivalent egg-derived vaccine, with respect to humoral immune response and was superior with respect to cellular response. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1149 / 1158
页数:10
相关论文
共 33 条
[1]  
Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250
[2]   CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED CYTOTOXIC T-LYMPHOCYTES ARE NOT NECESSARY FOR HETEROTYPIC IMMUNITY TO INFLUENZA [J].
BENDER, BS ;
BELL, WE ;
TAYLOR, S ;
SMALL, PA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1195-1200
[3]   Cytokine production after influenza vaccination in a healthy elderly population [J].
Bernstein, ED ;
Gardner, EM ;
Abrutyn, E ;
Gross, P ;
Murasko, DM .
VACCINE, 1998, 16 (18) :1722-1731
[4]  
BUTCHKO GM, 1978, J IMMUNOL, V121, P2381
[5]  
Casali P, 1996, CURR TOP MICROBIOL, V210, P167
[6]  
CAVALLISFORZA L, 1972, BIOMETRIE GRUNDZUGE, P159
[7]   MUCOSAL IMMUNOADJUVANT ACTIVITY OF LIPOSOMES - INDUCTION OF SYSTEMIC IGG AND SECRETORY IGA RESPONSES IN MICE BY INTRANASAL IMMUNIZATION WITH AN INFLUENZA SUBUNIT VACCINE AND COADMINISTERED LIPOSOMES [J].
DEHAAN, A ;
GEERLIGS, HJ ;
HUCHSHORN, JP ;
VANSCHARRENBURG, GJM ;
PALACHE, AM ;
WILSCHUT, J .
VACCINE, 1995, 13 (02) :155-162
[8]   Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use [J].
Deliyannis, G ;
Jackson, DC ;
Dyer, W ;
Bates, J ;
Coulter, A ;
Harling-McNabb, L ;
Brown, LE .
VACCINE, 1998, 16 (20) :2058-2068
[9]   GENERATION OF BOTH CROSS-REACTIVE AND VIRUS-SPECIFIC T-CELL POPULATIONS AFTER IMMUNIZATION WITH SEROLOGICALLY DISTINCT INFLUENZA-A VIRUSES [J].
EFFROS, RB ;
DOHERTY, PC ;
GERHARD, W ;
BENNINK, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 145 (03) :557-568
[10]   Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS) [J].
Ennis, FA ;
Cruz, J ;
Jameson, J ;
Klein, M ;
Burt, D ;
Thipphawong, J .
VIROLOGY, 1999, 259 (02) :256-261